Grand Pharmaceutical Group Company Description

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products.

It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products.

In addition, the company provides bio-pesticides and additives; disposal surgical products; and Chinese medicine and health food products, as well as engages in the treatment of sewage.

Grand Pharmaceutical Group Limited has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and development.

It operates in the People’s Republic of China, the rest of Asia, the United States, Europe, and internationally.

The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited. The company was incorporated in 1995 and is based in Central, Hong Kong.

Grand Pharmaceutical Group Limited

Country	Bermuda
Founded	1995
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	10,534
CEO	Chao Zhou

Contact Details

Address: The Center Central Hong Kong
Website	grandpharm.com

Stock Details

Ticker Symbol	0512
Exchange	Hong Kong Stock Exchange
Fiscal Year	January - December
Reporting Currency	HKD
ISIN Number	BMG210A71016
SIC Code	2834

Key Executives

Name	Position
Chao Zhou	Chief Executive Officer and Executive Director
Dr. Weikun Tang	Executive Chairman
Guang Yang	Executive Director
Liu Hu	Investor Relations Director
Chit Yee Lam	Executive Director
Tin Chung Foo CPA (Aust.), HKICPA	Company Secretary
Xiaofeng Shi	Chairman of Grand Pharm (China)
Xiaojie Chen	Vice President